XML 45 R34.htm IDEA: XBRL DOCUMENT v3.22.1
Capital Stock and Reserves (Tables)
3 Months Ended
Mar. 31, 2022
Equity [Abstract]  
Stock Compensation

 

Three Months Ended

 

 

March 31,

 

(In thousands of U.S. Dollars)

2022

 

 

2021

 

Cost and expenses applicable to revenues

$

 

239

 

 

$

 

294

 

Selling, general and administrative expenses

 

 

5,726

 

 

 

 

4,944

 

Research and development

 

 

87

 

 

 

 

69

 

 

$

 

6,052

 

 

$

 

5,307

 

Stock-based Compensation by Plan Type

The following table summarizes the Company’s share-based compensation expense by each award type:

 

 

Three Months Ended

 

 

March 31,

 

(In thousands of U.S. Dollars)

2022

 

 

2021

 

Stock Options

$

 

207

 

 

$

 

351

 

Restricted Share Units

 

 

3,411

 

 

 

 

3,151

 

Performance Stock Units

 

 

1,729

 

 

 

 

1,014

 

IMAX China Stock Options

 

 

34

 

 

 

 

56

 

IMAX China Long Term Incentive Plan Restricted Share Units

 

 

497

 

 

 

 

632

 

IMAX China Long Term Incentive Plan Performance Stock Units

 

 

174

 

 

 

 

103

 

 

$

 

6,052

 

 

$

 

5,307

 

Schedule of Share-based Compensation, Stock Options, Activity

The following table summarizes the activity under the Company’s Stock Option Plan (“SOP”) and the IMAX Corporation Second Amended and Restated Long-Term Incentive Plan (as may be amended, “IMAX LTIP”) for the three months ended March 31, 2022 and 2021:

 

 

 

Number of Shares

 

 

Weighted Average Exercise
Price Per Share

 

 

 

2022

 

 

2021

 

 

2022

 

 

2021

 

Stock options outstanding, beginning of period

 

 

3,736,157

 

 

 

4,892,962

 

$

 

26.61

 

 

$

 

26.81

 

Granted

 

 

 

 

 

 

 

 

 

 

 

 

 

Exercised

 

 

 

 

 

(38,754

)

 

 

 

 

 

 

21.26

 

Forfeited

 

 

 

 

 

(44,362

)

 

 

 

 

 

 

23.12

 

Expired

 

 

(126,569

)

 

 

(885,698

)

 

 

33.61

 

 

 

 

28.31

 

Cancelled

 

 

(2,197

)

 

 

(10,917

)

 

 

32.50

 

 

 

 

27.20

 

Stock options outstanding, end of period

 

 

3,607,391

 

 

 

3,913,231

 

 

 

26.36

 

 

 

 

26.56

 

Stock options exercisable, end of period

 

 

3,524,298

 

 

 

3,615,079

 

 

 

26.45

 

 

 

 

26.93

 

Restricted Stock Units Activity under the IMAX LTIP

The following table summarizes the activity in respect of RSUs issued under the IMAX LTIP for the three months ended March 31, 2022 and 2021:

 

 

 

Number of Awards

 

 

Weighted Average Grant Date
Fair Value Per Share

 

 

 

2022

 

 

2021

 

 

 

2022

 

 

 

2021

 

RSUs outstanding, beginning of period

 

 

1,457,883

 

 

 

1,564,838

 

 

$

 

19.16

 

 

$

 

18.33

 

Granted

 

 

636,427

 

 

 

754,778

 

 

 

 

19.64

 

 

 

 

20.94

 

Vested and settled

 

 

(648,527

)

 

 

(523,573

)

 

 

 

18.78

 

 

 

 

18.82

 

Forfeited

 

 

(1,328

)

 

 

(60,329

)

 

 

 

14.84

 

 

 

 

20.08

 

RSUs outstanding, end of period

 

 

1,444,455

 

 

 

1,735,714

 

 

 

 

19.54

 

 

 

 

19.26

 

Performance Stock Units Activity under the IMAX LTIP

The following table summarizes the activity in respect of PSUs issued under the IMAX LTIP for the three months ended March 31, 2022 and 2021:

 

 

Number of Awards

 

 

Weighted Average Grant Date
Fair Value Per Share

 

 

 

2022

 

 

2021

 

 

 

2022

 

 

 

2021

 

PSUs outstanding, beginning of period

 

 

613,405

 

 

 

361,844

 

 

$

 

18.21

 

 

$

 

15.68

 

Granted

 

 

359,138

 

 

 

308,438

 

 

 

 

20.34

 

 

 

 

20.77

 

Forfeited

 

 

 

 

 

(2,526

)

 

 

 

 

 

 

 

14.84

 

PSUs outstanding, end of period

 

 

972,543

 

 

 

667,756

 

 

 

 

19.00

 

 

 

 

18.03

 

 

Basic and Diluted Per-share Computations

The following table reconciles the denominator of the basic and diluted weighted average share computations:

 

 

Three Months Ended

 

 

March 31,

 

(In thousands)

2022

 

 

2021

 

Issued and outstanding, beginning of period

 

 

58,654

 

 

 

 

58,921

 

Weighted average number of shares (repurchased) issued, net

 

 

(80

)

 

 

 

91

 

Weighted average number of shares outstanding — basic

 

 

58,574

 

 

 

 

59,012

 

Weighted average effect of potential common shares, if dilutive

 

 

 

 

 

 

 

Weighted average number of shares outstanding — diluted

 

 

58,574

 

 

 

 

59,012